New York, NY – TheOTCReports.com tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting TheOTCReports.com
Today’s alerts include: Cell MedX Corp. (OTCQB: CMXC) $.32
TheOTCReports.com strives to bring our knowledge of the marketplace and explosive growth opportunities directly to our qualified subscribers. By exploring companies that have yet to receive any major market exposure, our clients can position themselves before a market upsurge occurs allowing for a profitable entry into an equity.
Our strength lies in finding these undervalued and under-marketed companies and delivering our research to our clients. Today we have initiated a profile on Cell MedX Corp. which is available at http://theotcreports.com/profile-cmxc.htm which recently announced it introduced Ongoing eBalance Pro Trial Observations Online.
About Cell MedX Corp. (OTCQB: CMXC)
Cell MedX Corp. is a development stage company focused on the commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications
Recent News: http://goo.gl/8OWY73
Cell MedX Corp.
For further information visit: www.cellmedx.com.
Or phone: 1-844-238-2692
KeyWords: Diabetes Study, Diabetes, Type 1 diabetes, Type 2 diabetes, Diabetes Symptoms, Insulin, Diabetes Symptoms, Diabetes Causes, Diabetes Treatments, International Diabetic Federation, American Diabetes Association, Canadian Diabetes Association.ADA, CDA, IDF